295 related articles for article (PubMed ID: 23150673)
21. Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide.
Webster S; Bonnell B; Rogers J
Am J Pathol; 1997 May; 150(5):1531-6. PubMed ID: 9137079
[TBL] [Abstract][Full Text] [Related]
22. Localization and cell association of C1q in Alzheimer's disease brain.
Afagh A; Cummings BJ; Cribbs DH; Cotman CW; Tenner AJ
Exp Neurol; 1996 Mar; 138(1):22-32. PubMed ID: 8593893
[TBL] [Abstract][Full Text] [Related]
23. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease.
Rolyan H; Feike AC; Upadhaya AR; Waha A; Van Dooren T; Haass C; Birkenmeier G; Pietrzik CU; Van Leuven F; Thal DR
J Neural Transm (Vienna); 2011 May; 118(5):699-712. PubMed ID: 21210284
[TBL] [Abstract][Full Text] [Related]
24. Astrocytes from old Alzheimer's disease mice are impaired in Aβ uptake and in neuroprotection.
Iram T; Trudler D; Kain D; Kanner S; Galron R; Vassar R; Barzilai A; Blinder P; Fishelson Z; Frenkel D
Neurobiol Dis; 2016 Dec; 96():84-94. PubMed ID: 27544484
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation of the amyloid β-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity.
Kumar S; Wirths O; Stüber K; Wunderlich P; Koch P; Theil S; Rezaei-Ghaleh N; Zweckstetter M; Bayer TA; Brüstle O; Thal DR; Walter J
Acta Neuropathol; 2016 Apr; 131(4):525-37. PubMed ID: 26898910
[TBL] [Abstract][Full Text] [Related]
26. Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease.
Fonseca MI; Zhou J; Botto M; Tenner AJ
J Neurosci; 2004 Jul; 24(29):6457-65. PubMed ID: 15269255
[TBL] [Abstract][Full Text] [Related]
27. Cultured rat microglia express C1q and receptor for C1q: implications for amyloid effects on microglia.
Korotzer AR; Watt J; Cribbs D; Tenner AJ; Burdick D; Glabe C; Cotman CW
Exp Neurol; 1995 Aug; 134(2):214-21. PubMed ID: 7556541
[TBL] [Abstract][Full Text] [Related]
28. miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q.
Xu N; Li AD; Ji LL; Ye Y; Wang ZY; Tong L
Eur J Histochem; 2019 May; 63(2):. PubMed ID: 31060348
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
30. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
31. The p38 mitogen-activated protein kinase signaling pathway is involved in regulating low-density lipoprotein receptor-related protein 1-mediated β-amyloid protein internalization in mouse brain.
Ma KG; Lv J; Hu XD; Shi LL; Chang KW; Chen XL; Qian YH; Yang WN; Qu QM
Int J Biochem Cell Biol; 2016 Jul; 76():75-86. PubMed ID: 27163530
[TBL] [Abstract][Full Text] [Related]
32. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
33. Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.
Liu CC; Hu J; Zhao N; Wang J; Wang N; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
J Neurosci; 2017 Apr; 37(15):4023-4031. PubMed ID: 28275161
[TBL] [Abstract][Full Text] [Related]
34. Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity.
Severini C; Lattanzi R; Maftei D; Marconi V; Ciotti MT; Petrocchi Passeri P; Florenzano F; Del Duca E; Caioli S; Zona C; Balboni G; Salvadori S; Nisticò R; Negri L
Sci Rep; 2015 Oct; 5():15301. PubMed ID: 26477583
[TBL] [Abstract][Full Text] [Related]
35. Functional role of lipoprotein receptors in Alzheimer's disease.
Jaeger S; Pietrzik CU
Curr Alzheimer Res; 2008 Feb; 5(1):15-25. PubMed ID: 18288927
[TBL] [Abstract][Full Text] [Related]
36. Influence of complement protein C1q or complement receptor C5aR1 on gut microbiota composition in wildtype and Alzheimer's mouse models.
Petrisko TJ; Gargus M; Chu SH; Selvan P; Whiteson KL; Tenner AJ
J Neuroinflammation; 2023 Sep; 20(1):211. PubMed ID: 37726739
[TBL] [Abstract][Full Text] [Related]
37. Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Aβ by microglia.
Fu H; Liu B; Frost JL; Hong S; Jin M; Ostaszewski B; Shankar GM; Costantino IM; Carroll MC; Mayadas TN; Lemere CA
Glia; 2012 May; 60(6):993-1003. PubMed ID: 22438044
[TBL] [Abstract][Full Text] [Related]
38. Initiators of Classical and Lectin Complement Pathways Are Differently Engaged after Traumatic Brain Injury-Time-Dependent Changes in the Cortex, Striatum, Thalamus and Hippocampus in a Mouse Model.
Ciechanowska A; Ciapała K; Pawlik K; Oggioni M; Mercurio D; De Simoni MG; Mika J
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375205
[TBL] [Abstract][Full Text] [Related]
39. Intracerebroventricular passive immunization with anti-oligoAbeta antibody in TgCRND8.
Chauhan NB
J Neurosci Res; 2007 Feb; 85(2):451-63. PubMed ID: 17086547
[TBL] [Abstract][Full Text] [Related]
40. C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar Aβ amyloid and preserves memory in a mouse model of familial Alzheimer's disease.
Panayiotou E; Fella E; Andreou S; Papacharalambous R; Gerasimou P; Costeas P; Angeli S; Kousiappa I; Papacostas S; Kyriakides T
PLoS One; 2019; 14(12):e0225417. PubMed ID: 31809505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
